HBM Partners
Climate Impact & Sustainability Data (2021, 2022-2023, 2023)
Reporting Period: 2021
Environmental Metrics
ESG Focus Areas
- Environmental
- Social
- Governance
- UN Sustainable Development Goals (SDGs)
Environmental Achievements
- HBM portfolio companies have inherently low carbon emissions and natural resource use due to their R&D focus.
Social Achievements
- HBM actively contributes to improvements in health and well-being by providing capital to firms within the healthcare industry.
- HBM promotes diversity in the workplace and is an equal opportunities employer.
Governance Achievements
- HBM adheres to the highest standards and values of business conduct and implements appropriate preventive procedures against illegal or harmful practices.
- HBM actively influences its portfolio companies’ strategies with respect to ESG principles through active ownership (proxy voting for public companies and board representation for private companies).
Climate Goals & Targets
Environmental Challenges
- Lack of standardized and comparable frameworks for measuring ESG/SDG performance leading to greenwashing.
- Absence of external rating providers for private companies, resulting in reliance on company management information.
Mitigation Strategies
- HBM monitors developments in regulatory frameworks and investor demand proactively.
- HBM uses ISS DataDesk and ISS ESG Fund Rating for monthly ESG/SDG performance screening of public portfolio companies.
- HBM performs semi-annual portfolio reviews for private equity investments, including ESG/SDG related developments.
- HBM relies on traditional investment parameters when ESG/SDG data is unavailable for non-transparent assets.
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: SFDR (Sustainable Finance Disclosure Regulation)
UN Sustainable Development Goals
- 3
- 5
- 8
- 9
- 10
- 12
- 13
HBM's investment in healthcare contributes to several SDGs, particularly those related to health, gender equality, economic growth, innovation, reduced inequalities, responsible consumption, and climate action.
Reporting Period: 2022-2023
Environmental Metrics
Climate Goals & Targets
Environmental Challenges
- Declining valuations for technology and growth stocks due to inflation and rising interest rates.
- Strong valuation corrections in the small and medium-sized company segment.
- Slowing economic growth and restrictive Covid-19 policies in China affecting Cathay Biotech valuation.
- US FDA denial of marketing approval for omburtamab by portfolio company Y-mAbs Therapeutics.
Mitigation Strategies
- Four profitable acquisitions (Turning Point Therapeutics, Sierra Oncology, ChemoCentryx, Biohaven Pharmaceuticals).
- Numerous follow-on investments in existing private companies.
- Selective expansion of the public company portfolio using favorable valuation levels.
- Continued distribution policy with a planned yield of 3.5 percent.
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Period: 2023
Environmental Metrics
ESG Focus Areas
- Environmental
- Social
- Governance
- UN Sustainable Development Goals (SDGs)
Social Achievements
- Promoting diversity in the workplace
- Providing capital to firms within the healthcare industry, creating jobs and a dynamic working environment
Governance Achievements
- Adhering to laws and regulations; implementing preventive procedures against illegal or harmful practices, bribery, corruption, collusion and money laundering
- Annual training for all employees on HBM policies
Climate Goals & Targets
Environmental Challenges
- Lack of standardized and comparable frameworks for measuring ESG/SDG performance leading to greenwashing
- Absence of external rating providers for private companies, resulting in reliance on management information
Mitigation Strategies
- Closely monitoring developments in regulatory frameworks and investor demand to adapt accordingly
- Implementing processes exceeding Art. 6 SFDR requirements
- Considering a potential classification of Art. 8 SFDR if reasonably feasible
- Relying on traditional parameters for investment decisions and monitoring in the absence of ESG/SDG data for non-transparent assets
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: SFDR
UN Sustainable Development Goals
- Goal 3: Good health and well-being
- Goal 5: Gender equality
- Goal 8: Decent work and economic growth
- Goal 9: Industry, innovation and infrastructure
- Goal 10: Reduced inequalities
- Goal 12: Responsible consumption and production
- Goal 13: Climate action
HBM's investment in healthcare contributes to improving health and well-being; active ownership influences portfolio companies' strategies regarding gender equality, decent work, responsible consumption, climate action, and reducing inequalities; investments promote industry innovation and infrastructure.